Andhra Paper
- Market cap
- ₹ 1,256 Cr.
- P/E
- 44.6x
- P/B
- 0.66x
- 52-week range
- 58 – 79.79
- ROE
- −2%
- ROCE
- 0%
- Dividend yield
- 0.8%
- Debt / equity
- 0.12
- Sector
- Paper, Forest & Jute Products
- Industry
- Paper & Paper Products
- Listed on
- NSE, BSE
About
Andhra Paper Limited is an India-based integrated paper and pulp manufacturer. The Company produces writing, printing and copier paper for foreign and domestic markets. Its brands include Andhra Truprint Ultra (HB), Andhra Primavera, Andhra Primavera White, Andhra Truprint Ivory, Andhra CCS, Andhra Natural Shade, Andhra Writechoice (SS), Andhra Rhodamine, Andhra Splendor, Andhra Pearlwhite, Andhra Thermal Base, Andhra Hi-Brite Blade Wrapper, Andhra Sketch Choice, Andhra Kraft (Ribbed & Plain), Andhra Stiffener, among others. Its products are used as account books, annual reports, base paper for chromo/art paper/art board, bills, blade wrapping, book printing, brochures, calendars, cash books, challans, children's books, computer forms, covers, diaries, envelopes, files/folders, and more. It owns and operates two manufacturing units located in the State of Andhra Pradesh, India, one at Rajamahendravaram and the other at Kadiyam in East Godavari District.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Paper & Paper Products: 54 companies →Andhra Paper against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)44.6 against a typical 15.9: pricier than most peers (1st = cheapest).43rd of 52
- Sales growth+0.3% against a typical +10% from a year earlier.33rd of 44
- Profit growth+42.9% against a typical +23% from a year earlier.16th of 33
- Share price, 3 months+5.8% against a typical −5.7%.13th of 50
- Size₹ 1,256.3 Cr. market value against a typical ₹ 86.8 Cr. (1st = largest).4th of 49
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
High safety
Rated AA by 2 agencies- All agencies agree and none has raised a warning.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| India Ratings | IND AA; IND A1+ | Stable | 21 May 2026 |
| CARE | Withdrawn | — | 5 Dec 2025 |
| ICRA | [ICRA]AA | Stable | 4 Dec 2025 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 21 May 2026 | Reaffirmed | IND AA | — | India Ratings | ₹ 450 Cr. | |
| 5 Dec 2025 | Withdrawn | — | — | CARE | — | |
| 4 Dec 2025 | New rating | [ICRA]AA | — | ICRA | ₹ 350 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 30 Oct 2026Upcoming | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 4 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 14 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 4 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 6 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 5 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 8 May 2025 | Financial Results/Dividend | Consider and approve Audited Financial Results of the Company for the quarter andyear ended March 31, 2025 and Consider and recommend the final dividend, if any, for the financial year 2024-25. |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 482 | 477 | 364 | 316 | 432 | 386 | 407 | 393 | 362 | 419 | 527 | 394 |
| Expenses | 351 | 367 | 329 | 282 | 380 | 357 | 387 | 360 | 369 | 403 | 502 | 345 |
| Operating Profit | 131 | 110 | 35 | 34 | 52 | 28 | 20 | 34 | −7 | 15 | 25 | 49 |
| OPM % | 27% | 23% | 10% | 11% | 12% | 7% | 5% | 9% | −1.9% | 3.7% | 4.8% | 12% |
| Other Income | 21 | 24 | 28 | 25 | 30 | 15 | 18 | 27 | 10 | 29 | 17 | 22 |
| Interest | 1 | 1 | 1 | 2 | 4 | 5 | 7 | 6 | 4 | 5 | 4 | 3 |
| Depreciation | 17 | 17 | 17 | 21 | 21 | 22 | 25 | 26 | 27 | 27 | 27 | 27 |
| Profit before tax | 135 | 116 | 46 | 36 | 58 | 17 | 6 | 29 | −28 | 12 | 12 | 41 |
| Tax % | 25% | 29% | 16% | 23% | 28% | 32% | −27% | 27% | −27% | 19% | 34% | 25% |
| Net Profit | 100 | 82 | 38 | 28 | 42 | 12 | 8 | 21 | −20 | 10 | 8 | 30 |
| EPS in Rs | 5.04 | 4.15 | 1.93 | 1.39 | 2.1 | 0.59 | 0.39 | 1.07 | −1.02 | 0.5 | 0.39 | 1.52 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 4%
- 5 Years
- 14%
- 3 Years
- −7%
- TTM
- 5%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- −67%
- 10 Years
- 1%
- 5 Years
- 6%
- 3 Years
- −11%
- TTM
- —
- 10 Years
- 14%
- 5 Years
- 13%
- 3 Years
- 6%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Andhra Paper | ₹ 65.81 | ₹ 1,256 Cr. | 44.6x | 0.7x | −2% | — |
| Aditya Birla Real Estate | ₹ 1,043.35 | ₹ 11,654 Cr. | — | 4.3x | −8.7% | −83% |
| JK Paper | ₹ 356.65 | ₹ 6,450 Cr. | 24x | 1.2x | 5.1% | 3.9% |
| KS Smart Technologies Ltd | ₹ 77.34 | ₹ 1,269 Cr. | 14.6x | 7.5x | 49.9% | 7.4% |
| GHV Infra Projects | ₹ 244.90 | ₹ 1,937 Cr. | 34.4x | 12.4x | 55.9% | 7.9% |
| Seshasayee Paper and Boards | ₹ 199.05 | ₹ 1,259 Cr. | 16.2x | 0.7x | 4.1% | 4.8% |
Management
- Virendraa Bangur
- Non-Executive Vice Chairman Of The Board
- Rajesh Bothra
- Chief Financial Officer
- Sura Reddy Mallidi
- Senior Vice President - Mill Operations
- Bijay Kumar Sanku
- Compliance Officer, Company Secretary
- Saurabh Bangur
- Managing Director, Executive Director
- Mukesh Jain
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.